Impact of Adjuvant Trastuzumab on Locoregional Failure Rates in the Randomized Clinical Trial: NCCTG N9831 (Alliance) Study
- Citation:
- Cancer vol 126 (24) 5239-46
- Year:
- 2020
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Pharmas:
- Genentech
- Grants:
- U10CA180821, U10CA180882, UG1CA233253, UG1CA233328, UG1CA232760, U10CA180820, U10CA180828 (ECOG-ACRIN), U10CA180888 (SWOG)
- Corr. Author:
- Authors:
- Carlos E. Vargas Cameron S. Thorpe Amylou C. Dueck Kathleen S. Tenner Nancy E. Davidson Silvana Martino Thomas M. Pisansky E. Shelley Hwang Michele Y. Halyard Barbara A. Pockaj Edith A. Perez
- Networks:
- LAPS-MN026, LAPS-NC010, PR028, SANFORD
- Study
- NCCTG-N9831
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: